Pharming Group N.V. ADR
(PHAR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Gross Profit | 470 | 240 | 250 | 70 | 30 |
| Operating Expenses | 1,260 | 1,870 | 1,470 | 1,400 | 1,260 |
| Operating Income | -1,260 | -1,870 | -1,470 | -1,400 | -1,260 |
| Pre-tax Income | -1,260 | -1,870 | -1,470 | -1,400 | -1,260 |
| Net Income Continuous | -1,260 | -1,870 | -1,470 | -1,400 | -1,260 |
| Net Income | $-1,260 | $-1,870 | $-1,470 | $-1,400 | $-1,260 |
| EBITDA(a) | $-790 | $-1,460 | $-1,050 | $-990 | $-850 |